SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

China Grants Priority Review to Akeso’s Ivonescimab for Biliary Tract Cancer

China granted priority review to Akeso’s ivonescimab for first-line biliary tract cancer.

Related stories